EN
抗体药类似物
Research Grade Nadecnemab
All
  • CatalogTD-HT009016
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsREGN5069,CAS:2377679-19-9
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Nadecnemab


Catalog No. TD-HT009016
Species reactivity Human
Applications Research Grade Biosimilar
Host species Human
Isotype IgG4-Kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target GFR-alpha-3, GDNF receptor alpha-3, GDNF family receptor alpha-3, GDNFR-alpha-3, GFRA3
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession O60609
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names REGN5069,CAS:2377679-19-9
Background Nadecnemab is an IgG4κ antibody targeting to GFRA3, glial cell derived neurotrophic factor family receptor alpha 3. Nadecnemab can be used for research of osteoarthritis of the knee/pain.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HT009016_1.jpg
SEC-HPLC
 
SEC-HPLC detection for Research Grade Nadecnemab.
TD-HT009016_2.jpg
Bioactivity
 
Detects GFRA3 in indirect ELISAs.